Temple, the health-tech venture founded by Deepinder Goyal, has unveiled a new biomarker called “Entropy”, which it claims can track the body’s metabolic activity in real time. The announcement marks one of the most ambitious attempts yet to move wearable technology beyond traditional fitness metrics such as heart rate and step counts.
The company describes Entropy as a live measure of how much energy the body is using at any given moment. Displayed on a scale of 1 to 250, the score changes continuously throughout the day in response to physical activity, stress levels, sleep quality, nutrition, recovery and other lifestyle factors.
Unlike conventional wearables that primarily rely on heart-rate data, Temple says Entropy captures metabolic effort more accurately. Internal testing reportedly showed a close match between Entropy readings and laboratory calorimeter measurements, suggesting the metric may provide deeper insights into how the body functions under different conditions.
Goyal believes the technology could help users better understand the relationship between daily habits and long-term health. Temple has introduced separate measures for peak performance and resting metabolic state, allowing users to monitor both fitness capacity and recovery levels over time.
The development has sparked excitement among wearable technology enthusiasts, particularly as demand grows for more personalised health insights. At the same time, scientists and medical experts have urged caution, noting that the company has yet to publish detailed research or peer-reviewed evidence validating the biomarker.
With the wearable health market becoming increasingly competitive, Temple’s latest innovation positions the startup as a company aiming to reshape how people measure wellness. The coming months will likely determine whether Entropy emerges as a breakthrough health metric or remains an intriguing experimental concept.
Also Read: Jahangir Khan’s wife held after police station attack
